Andrea Stancati MD, Rheumatologist
Belgium
Global Head of Immunology Early Projects & IBD @ UCB
Pharmaceuticals
Education
Università Politecnica delle Marche 2000 — 2003
Rheumatology, Medicine, Magna cum Laude
Università degli Studi di Parma 1993 — 1999
MD, Medicine & Surgery
Experience
UCB July 2015 - Present
Novo Nordisk September 2014 - June 2015
Novartis April 2014 - August 2014
Novartis August 2012 - March 2014
Novartis August 2011 - August 2012
Hoffmann-La Roche September 2008 - July 2011
UCB Pharma September 2007 - September 2008
UCB Pharma August 2006 - September 2007
Private Practice November 2003 - July 2006
University of Ancona October 1999 - July 2006
Skills
Rheumatoid Arthritis, ICH-GCP, Teaching, Medical affairs, Study Design, Outcomes Research, Protocol Development, Inflammation, Key Opinion Leader..., GCP, Clinical Pharmacology, Pharmaceutical Industry, Rheumatology, CTMS, Due Diligence, Biotechnology, Translational Medicine, Inflammatory bowel..., Successful track record, Targeted Therapies, Pharmacoepidemiology, Pharmaceuticals, Biostatistics, Biologics, Medical Affairs, Psoriasis, Musculoskeletal..., Osteoporosis, Gout, Pharmacovigilance, Clinical Study Design, Scleroderma, Clinical Trials, Immunology, Epidemiology, Clinical Development, Regulatory Submissions, Market Access, Pharmacoeconomics, autoinflammatory..., Health Economics, Health Outcomes, Public Speaking, interactions with..., Clinical Data Management, Autoimmune Diseases, Medical Imaging, Clinical Research, Regulatory Filings, Strategic Thinking